Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

Generation of Mice with Hepatocyte-Specific Conditional Deletion of Notum.

Canal F, Charawi S, Grimber G, Houbron C, Drouet V, Colnot S, Terris B, Cavard C, Perret C.

PLoS One. 2016 Mar 14;11(3):e0150997. doi: 10.1371/journal.pone.0150997. eCollection 2016.

2.

Wnt/beta-catenin pathway in hepatocellular carcinoma pathogenesis and liver physiology.

Cavard C, Colnot S, Audard V, Benhamouche S, Finzi L, Torre C, Grimber G, Godard C, Terris B, Perret C.

Future Oncol. 2008 Oct;4(5):647-60. doi: 10.2217/14796694.4.5.647. Review.

PMID:
18922122
3.

Cholestasis is a marker for hepatocellular carcinomas displaying beta-catenin mutations.

Audard V, Grimber G, Elie C, Radenen B, Audebourg A, Letourneur F, Soubrane O, Vacher-Lavenu MC, Perret C, Cavard C, Terris B.

J Pathol. 2007 Jul;212(3):345-52.

PMID:
17487939
4.

Differential effects of inactivated Axin1 and activated beta-catenin mutations in human hepatocellular carcinomas.

Zucman-Rossi J, Benhamouche S, Godard C, Boyault S, Grimber G, Balabaud C, Cunha AS, Bioulac-Sage P, Perret C.

Oncogene. 2007 Feb 1;26(5):774-80. Epub 2006 Sep 11.

PMID:
16964294
5.

Overexpression of regenerating islet-derived 1 alpha and 3 alpha genes in human primary liver tumors with beta-catenin mutations.

Cavard C, Terris B, Grimber G, Christa L, Audard V, Radenen-Bussiere B, Simon MT, Renard CA, Buendia MA, Perret C.

Oncogene. 2006 Jan 26;25(4):599-608.

PMID:
16314847
6.

Functional differences between hepcidin 1 and 2 in transgenic mice.

Lou DQ, Nicolas G, Lesbordes JC, Viatte L, Grimber G, Szajnert MF, Kahn A, Vaulont S.

Blood. 2004 Apr 1;103(7):2816-21. Epub 2003 Nov 6.

PMID:
14604961
7.

Iron overload in mice expressing HFE exclusively in the intestinal villi provides evidence that HFE regulates a functional cross-talk between crypt and villi enterocytes.

Fergelot P, Ropert-Bouchet M, Abgueguen E, Orhant M, Radosavljevic M, Grimber G, Jouan H, Le Gall JY, Mosser J, Gilfillan S, Bahram S.

Blood Cells Mol Dis. 2002 May-Jun;28(3):348-60.

PMID:
12367579
8.

Effect of Bcl-2 expression on hepatic preneoplasia in mice.

Gillet R, Grimber G, Cavard C, Bennoun M, Mignon A, Briand P, Joulin V.

Cancer Lett. 2002 Mar 28;177(2):189-95.

PMID:
11825666
9.

Hepatic expression of SV40 small-T antigen blocks the in vivo CD95-mediated apoptosis.

Gillet R, Cavard C, Grimber G, Briand P, Joulin V.

Biochem Biophys Res Commun. 2001 Jun 8;284(2):369-76.

PMID:
11394888
10.

The consequence of p53 overexpression for liver tumor development and the response of transformed murine hepatocytes to genotoxic agents.

Gillet R, Grimber G, Bennoun M, Caron de Fromentel C, Briand P, Joulin V.

Oncogene. 2000 Jul 20;19(31):3498-507.

11.

Targeted expression of a dominant-negative EGF-R in the kidney reduces tubulo-interstitial lesions after renal injury.

Terzi F, Burtin M, Hekmati M, Federici P, Grimber G, Briand P, Friedlander G.

J Clin Invest. 2000 Jul;106(2):225-34.

12.

The amino-terminal region of SV40 large T antigen is sufficient to induce hepatic tumours in mice.

Bennoun M, Grimber G, Couton D, Seye A, Molina T, Briand P, Joulin V.

Oncogene. 1998 Sep 10;17(10):1253-9.

13.

Transgenic mice for MTCP1 develop T-cell prolymphocytic leukemia.

Gritti C, Dastot H, Soulier J, Janin A, Daniel MT, Madani A, Grimber G, Briand P, Sigaux F, Stern MH.

Blood. 1998 Jul 15;92(2):368-73.

PMID:
9657733
14.

Transgenic mice carrying the human beta 2-adrenergic receptor gene with its own promoter overexpress beta 2-adrenergic receptors in liver.

André C, Erraji L, Gaston J, Grimber G, Briand P, Guillet JG.

Eur J Biochem. 1996 Oct 15;241(2):417-24.

15.

Spi-1/PU.1 transgenic mice develop multistep erythroleukemias.

Moreau-Gachelin F, Wendling F, Molina T, Denis N, Titeux M, Grimber G, Briand P, Vainchenker W, Tavitian A.

Mol Cell Biol. 1996 May;16(5):2453-63.

16.

Protection of hepatocytes from Fas-mediated apoptosis by a non-transforming SV40 T-antigen mutant.

Rouquet N, Allemand I, Grimber G, Molina T, Briand P, Joulin V.

Cell Death Differ. 1996 Jan;3(1):91-6.

PMID:
17180059
17.

Compensatory apoptosis in response to SV40 large T antigen expression in the liver.

Allemand I, Grimber G, Kornprobst M, Bennoun M, Molina T, Briand P, Joulin V.

Oncogene. 1995 Dec 21;11(12):2583-90.

PMID:
8545115
18.

In vivo activity of the hepatitis B virus core promoter: tissue specificity and temporal regulation.

Billet O, Grimber G, Levrero M, Seye KA, Briand P, Joulin V.

J Virol. 1995 Sep;69(9):5912-6.

19.

Tat-induced lesions in transgenic mice do not correlate with the HIV-1 LTR transactivation.

Fergelot P, Molina T, Blanchet P, Grimber G, Duquenne O, Couton D, Zider A, Briand P, Cavard C.

C R Acad Sci III. 1995 Mar;318(3):329-37.

PMID:
7788501
20.

Hepatitis B virus X gene product acts as a transactivator in vivo.

Balsano C, Billet O, Bennoun M, Cavard C, Zider A, Grimber G, Natoli G, Briand P, Levrero M.

J Hepatol. 1994 Jul;21(1):103-9.

PMID:
7963409
21.

Cell-type-specific expression and regulation of a c-fos-NGF fusion gene in neurons and astrocytes of transgenic mice.

Onténiente B, Horellou P, Neveu I, Makeh I, Suzuki F, Bourdet C, Grimber G, Colin P, Brachet P, Mallet J, et al.

Brain Res Mol Brain Res. 1994 Feb;21(3-4):225-34.

PMID:
8170347
22.

In vitro manipulation of early mouse embryos induces HIV1-LTRlacZ transgene expression.

Vernet M, Cavard C, Zider A, Fergelot P, Grimber G, Briand P.

Development. 1993 Dec;119(4):1293-300.

23.

Dispensable role of the NF-kappa B sites in the UV-induction of the HIV-1 LTR in transgenic mice.

Zider A, Mashhour B, Fergelot P, Grimber G, Vernet M, Hazan U, Couton D, Briand P, Cavard C.

Nucleic Acids Res. 1993 Jan 11;21(1):79-86.

24.

The hepatitis B virus X gene product transactivates the HIV-LTR in vivo.

Balsano C, Billet O, Bennoun M, Cavard C, Zider A, Grimber G, Natoli G, Briand P, Levrero M.

Arch Virol Suppl. 1993;8:63-71.

PMID:
8260878
25.

Inherited haemolytic anaemia created by insertional inactivation of the alpha-spectrin gene.

Grimber G, Galand C, Garbarz M, Mattei MG, Cavard C, Zider A, Blanchet P, Boivin P, Briand P, Dhermy D.

Transgenic Res. 1992 Nov;1(6):268-74.

PMID:
1338695
26.

Diet-dependent carcinogenesis of pancreatic islets and liver in transgenic mice expressing oncogenes under the control of the L-type pyruvate kinase gene promoter.

Cartier N, Miquerol L, Tulliez M, Lepetit N, Levrat F, Grimber G, Briand P, Kahn A.

Oncogene. 1992 Jul;7(7):1413-22.

PMID:
1620553
27.

Tissue expression pattern directed in transgenic mice by the LTR of an HTLV-I provirus isolated from a case of tropical spastic paraparesis.

Gonzalez-Dunia D, Grimber G, Briand P, Brahic M, Ozden S.

Virology. 1992 Apr;187(2):705-10.

PMID:
1546464
28.

Transcriptional selectivity in early mouse embryos: a qualitative study.

Bonnerot C, Vernet M, Grimber G, Briand P, Nicolas JF.

Nucleic Acids Res. 1991 Dec;19(25):7251-7.

29.

Time-course development of differentiated hepatocarcinoma and lung metastasis in transgenic mice.

Dubois N, Bennoun M, Allemand I, Molina T, Grimber G, Daudet-Monsac M, Abelanet R, Briand P.

J Hepatol. 1991 Sep;13(2):227-39.

PMID:
1660504
30.

Neuronal-specific expression of human copper-zinc superoxide dismutase gene in transgenic mice: animal model of gene dosage effects in Down's syndrome.

Ceballos-Picot I, Nicole A, Briand P, Grimber G, Delacourte A, Defossez A, Javoy-Agid F, Lafon M, Blouin JL, Sinet PM.

Brain Res. 1991 Jun 28;552(2):198-214.

PMID:
1717112
31.

Expression of human Cu-Zn superoxide dismutase gene in transgenic mice: model for gene dosage effect in Down syndrome.

Ceballos I, Nicole A, Briand P, Grimber G, Delacourte A, Flament S, Blouin JL, Thevenin M, Kamoun P, Sinet PM.

Free Radic Res Commun. 1991;12-13 Pt 2:581-9.

PMID:
1829430
32.

In vivo activation by ultraviolet rays of the human immunodeficiency virus type 1 long terminal repeat.

Cavard C, Zider A, Vernet M, Bennoun M, Saragosti S, Grimber G, Briand P.

J Clin Invest. 1990 Oct;86(4):1369-74.

33.

Patterns of expression of position-dependent integrated transgenes in mouse embryo.

Bonnerot C, Grimber G, Briand P, Nicolas JF.

Proc Natl Acad Sci U S A. 1990 Aug;87(16):6331-5.

34.

Correction of mouse ornithine transcarbamylase deficiency by gene transfer into the germ line.

Cavard C, Grimber G, Dubois N, Chasse JF, Bennoun M, Minet-Thuriaux M, Kamoun P, Briand P.

Nucleic Acids Res. 1988 Mar 25;16(5):2099-110.

35.

A beta-galactosidase hybrid protein targeted to nuclei as a marker for developmental studies.

Bonnerot C, Rocancourt D, Briand P, Grimber G, Nicolas JF.

Proc Natl Acad Sci U S A. 1987 Oct;84(19):6795-9.

36.

A new family affected by the syndrome of hyperornithinaemia, hyperammonaemia and homocitrullinuria.

Rodes M, Ribes A, Pineda M, Alvarez L, Fabregas I, Fernandez Alvarez E, Coude FX, Grimber G.

J Inherit Metab Dis. 1987;10(1):73-81.

PMID:
3106719
37.

Modified colorimetry of free fatty acids in plasma in the presence of valproic acid.

Coudé FX, Grimber G.

Clin Chem. 1985 Jun;31(6):1101. No abstract available.

PMID:
3922648
38.

Potentiation by ammonia of the metabolic effects of pent-4-enoate in isolated rat hepatocytes.

Coudé FX, Grimber G, Parvy P, Rabier D, Bardet J.

Biochem J. 1984 Nov 15;224(1):263-7.

40.

Inhibition of urea synthesis by pent-4-enoic acid: potentiation by ammonia.

Coude FX, Grimber G.

Biochem Biophys Res Commun. 1984 Jan 13;118(1):47-52.

PMID:
6696766
41.

Role of N-acetylglutamate and acetyl-CoA in the inhibition of ureagenesis by isovaleric acid in isolated rat hepatocytes.

Coude FX, Grimber G, Parvy P, Rabier D.

Biochim Biophys Acta. 1983 Nov 22;761(1):13-6.

PMID:
6639961
42.

Inhibition of ureagenesis by valproate in rat hepatocytes. Role of N-acetylglutamate and acetyl-CoA.

Coude FX, Grimber G, Parvy P, Rabier D, Petit F.

Biochem J. 1983 Oct 15;216(1):233-6.

43.

Action of the antiepileptic drug, valproic acid, on fatty acid oxidation in isolated rat hepatocytes.

Coudé FX, Grimber G, Pelet A, Benoit Y.

Biochem Biophys Res Commun. 1983 Sep 15;115(2):730-6.

PMID:
6414476
44.

Characterization of enzymatic deficiencies of branched chain amino-acid catabolism in human fibroblasts by genetic complementation.

Coudé FX, Grimber G, Parvy P, Pham Dinh D, Bardet J, Saudubray JM.

Biochem Biophys Res Commun. 1983 Jul 18;114(1):175-82.

PMID:
6882421
45.

Developmental changes of citrullinogenesis, mitochondrial N-acetylglutamate content and N-acetylglutamate synthetase in fetal and neonatal rats.

Rabier D, Briand P, Coude FX, Petit F, Grimber G, Kamoun PP, Cathelineau L.

Biochimie. 1983 Jan;65(1):1-6.

PMID:
6403054
46.

Correlation between blood ammonia concentration and organic acid accumulation in isovaleric and propionic acidemia.

Coude FX, Ogier H, Grimber G, Parvy P, Pham Dinh D, Charpentier C, Saudubray JM.

Pediatrics. 1982 Jan;69(1):115-7. No abstract available.

PMID:
7054746
47.

A mechanism for valproate-induced hyperammonemia.

Coudé FX, Rabier D, Cathelineau L, Grimber G, Parvy P, Kamoun P.

Adv Exp Med Biol. 1982;153:153-61. No abstract available.

PMID:
6819763
48.

[Lysinuric protein intolerance: a severe hyperammonemia secondary to l-arginine deficiency (author's transl)]].

Coude FX, Ogier H, Charpentier C, Cathelineau L, Grimber G, Parvy P, Saudubray JM, Frezal J.

Arch Fr Pediatr. 1981 Dec;38 Suppl 1:829-35. French.

PMID:
6800334
49.

N-Acetyl glutamate synthetase in human liver: regulation of activity by L-arginine and N-acetylglutamate.

Coudé FX, Grimber G, Parvy P, Kamoun P.

Biochem Biophys Res Commun. 1981 Oct 15;102(3):1016-20. No abstract available.

PMID:
7306185
50.

A mechanism for valproate-induced hyperammonemia.

Coude FX, Rabier D, Cathelineau L, Grimber G, Parvy P, Kamoun PP.

Pediatr Res. 1981 Jun;15(6):974-5. No abstract available.

PMID:
6787550

Supplemental Content

Loading ...
Support Center